- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 26.9M sh |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $167.93M |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $190.32M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $325.85M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $343.3M |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $624.38M |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $661.41M |
| Current Assets | Q1 2025 · Mar 29, 2025 | $806.47M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $844.86M |
| Total Assets | Q1 2025 · Mar 29, 2025 | $2.08B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $2.11B |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 26.9M sh |
| Dividends Paid | Q1 2025 · Mar 30, 2024 | $9.15M |
| Capex | Q1 2025 · Mar 30, 2024 | $35.53M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | $34.24M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $1.39B |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $1.37B |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $0.86 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $0.86 |
| Sga Expense restated | Q1 2025 · Mar 30, 2024 | $267.65M |
| Net Income | Q1 2025 · Mar 30, 2024 | $23.17M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $27.36M |
| Gross Profit restated | Q1 2025 · Mar 30, 2024 | $295.01M |
| Revenue restated | Q1 2025 · Mar 30, 2024 | $1.18B |